Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Karuna Therapeutics Inc (NQ: KRTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Karuna Therapeutics Inc

< Previous 1 2 3 4 5 Next >
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why. 
Via Investor's Business Daily
Where Karuna Therapeutics Stands With Analysts
Over the past 3 months, 12 analysts have published their opinion on Karuna Therapeutics (NASDAQ:KRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Expert Ratings for Karuna Therapeutics
Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter: 
Via Benzinga
What 12 Analyst Ratings Have To Say About Karuna Therapeutics
Within the last quarter, Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings: 
Via Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
Via Benzinga
8 Analysts Have This to Say About Karuna Therapeutics
  Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter: 
Via Benzinga
Karuna Therapeutics: Q2 Earnings Insights
  Karuna Therapeutics (NASDAQ:KRTX) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
These names are benefitting from M&A, clinical data and promising regulatory actions. 
Via Investor's Business Daily
This Analyst Raises PT On Karuna Therapeutics By 100%; Wells Fargo Predicts $2,300 For This Stock
Piper Sandler boosted the price target on First Solar, Inc. (NASDAQ: FSLR) from $120 to $165. Piper Sandler analyst Kashy Harrison maintained an Overweight rating on the stock. First Solar shares rose... 
Via Benzinga
Coinbase, Trade Desk, H&R Block And Some Other Big Gainers From Wednesday
U.S. stocks closed higher on Wednesday following the release of inflation data. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
SVB Likes This 'Novel Antipsychotic'-Focused Stock
Via Benzinga
JMP Views Positive Phase 3 Data Equivalent To 'Schizophrenia Blockbuster' For This Stock
Via Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading. 
Via Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Nasdaq Turns Lower; Crude Oil Rises Over 1%
U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher
U.S. stocks traded higher this morning, following the release of strong jobs data on Friday. 
Via Benzinga
Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data
Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia. 
Via InvestorPlace
Top-Notch Karuna Therapeutics Breaks Out To Record High On Schizophrenia Win
Karuna Therapeutics easily beat expectations for its midstage test in schizophrenia. 
Via Investor's Business Daily
Why U.S. Stocks Are Trading Higher; Tyson Foods Earnings Miss Views
U.S. stocks traded higher this morning, following the release of strong jobs data on Friday. 
Via Benzinga
Karuna Therapeutics Shares Surge After Encouraging Data From Schizophrenia Candidate
Karuna Therapeutics Inc (NASDAQ: KRTX) has  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
Upgrades 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.